CJC-1295 Ipamorelin Blend

This growth-hormone–supporting peptide protocol is designed to align with the body’s natural GH release patterns, supporting muscle recovery, fat metabolism, and tissue repair when administered under fasted conditions.

$72.00

Add to Wishlist

For laboratory research use only. Not for human or animal use or consumption. Not a drug, food, dietary supplement, or cosmetic. Not approved by the FDA for any medical use.

Description

This peptide protocol is commonly studied for its ability to stimulate growth hormone (GH) release, supporting recovery, metabolic efficiency, and tissue repair. Timing and nutritional considerations play a critical role in maximizing its research potential.

Dosage Guidelines (Research Use)

General Dose (Morning Protocol):

  • 300–500 mcg, administered in the morning before workouts

  • Taken in a fasted state

  • 5 days per week

General Dose (Evening Protocol):

  • 300–500 mcg, administered in the evening or before sleep

  • Night-time administration aligns with the body’s natural GH secretion, which peaks during deep sleep—particularly in early sleep cycles

  • This timing may enhance outcomes related to muscle recovery, fat metabolism, and tissue repair

Cycle Length

  • 8–10 weeks

  • Recommended to follow with an extended off-cycle of 4–8 weeks to support receptor sensitivity and optimal response

Administration Notes

  • Carbohydrates and dietary fats can blunt growth hormone release

  • Best administered 30 minutes before eating or at least 2 hours after meals

  • Maintaining fasted conditions is critical for optimal GH-related research outcomes

Important Notes

  • Consistent timing improves protocol reliability

  • Dosage may be adjusted slightly for practical administration purposes

  • Minor variations in dosage are not expected to significantly impact observed responses

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 Ipamorelin Blend”

Your email address will not be published. Required fields are marked *